Recent Updates
Recently added Catalysts
TNGX Positive Sentiment Score: 75/100

Tango Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference

Wednesday, November 12, 2025 1 min read
Key Takeaway: Tango Therapeutics, Inc. (NASDAQ: TNGX) has announced its participation in the 2025 Jefferies Global Healthcare Conference, where CEO Barbara Weber will engage in a fireside chat. This event is scheduled for November 19, 2025. The live webcast will be accessible via the company's website, and a replay will be available for 90 days. Tango Therapeutics specializes in developing novel drug targets and therapies utilizing principles of precision medicine aimed at cancer treatment.

Conference Participation Details

Jefferies Global Healthcare Conference
Date: November 18, 2025
Time: 11:30 a.m. GMT / 6:30 a.m. ET
Location: London
Format: Fireside Chat

How to Access

Investors and the general public can listen to both sessions live at:

https://investor.viatris.com

Archived versions will be available following the live events for a limited time.

Market Sentiment Analysis

POSITIVE FACTORS

  • Tango Therapeutics' participation in a major healthcare conference highlights its strategic engagement with investors.
  • The presentation by the CEO underscores the company's commitment to transparency and investor relations.
  • The focus on precision medicine positions Tango Therapeutics as an innovative player in the oncology market.

Full Press Release Details

BOSTON, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a fireside chat at the 2025 Jefferies Global Healthcare Conference on Wednesday, November 19 at 4:30-4:55 PM GMT / 11:30-11:55am ET.
The live webcast will be available under the "Events & Presentations" tab on the “Investors” page of the Company's website on the day of the event. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.
About Tango Therapeutics
Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. For more information, please visit www.tangotx.com.
Investors and Media:

Frequently Asked Questions

When is Barbara Weber speaking at the Jefferies Conference?

Barbara Weber is scheduled to speak on November 19, 2025, from 4:30-4:55 PM GMT.

Where can I watch the webcast of the fireside chat?

The webcast can be watched on the 'Events & Presentations' tab of the Investors page.

How long will the webcast replay be available?

The replay of the webcast will be available for 90 days after the presentation.

What is Tango Therapeutics focused on?

Tango Therapeutics focuses on discovering drug targets for precision cancer medicine.

What principle does Tango use in their therapeutic development?

Tango uses the principle of synthetic lethality to develop cancer therapies.

Tags: TNGX Viatris Investor Conferences Healthcare Tango Therapeutics Jefferies Conference biotech precision medicine
Last updated: Nov 12, 2025

Conference Timeline

Nov 11, 2025
UBS Global Healthcare Conference
8:45 AM ET • Fireside Chat
Nov 18, 2025
Jefferies Global Healthcare
11:30 AM GMT • London